|
KMID : 0988920220200040431
|
|
Intestinal Research
2022 Volume.20 No. 4 p.431 ~ p.444
|
|
|
Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements
|
|
Park Yong-Eun
Lee Yoo-Jin
Chang Ji-Young
Song Hyun-Joo
Kim Duk-Hwan
Yang Young-Joo
Kim Byung-Chang
Lee Jae-Gon
Yang Hee-Chan
Choi Mi-Young
Kim Seong-Eun
Myung Seung-Jae
|
|
|
Abstract
|
|
|
|
Many unexpected problems have resulted from the unprecedented coronavirus disease 2019 (COVID-19) pandemic. The optimal management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic has also been a challenge. Therefore, the Korean Association for the Study of Intestinal Diseases (KASID) developed a consensus statement of experts regarding the management of IBD during the COVID-19 pandemic. This consensus statement made recommendations regarding the risk and treatment of COVID-19 in IBD patients. This statement emphasizes that IBD is not a risk factor for COVID-19, and care should be taken not to exacerbate IBD in patients in remission state by maintaining their medications, except for corticosteroids.
|
|
|
KEYWORD
|
|
|
SARS-CoV-2, COVID-19, Inflammatory bowel disease, Management
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|